Overweight and obesity: the significance of a depressed mood
Marieke Q Werrij1, Sandra Mulkens, Harm J Hospers
1Maastricht University, Faculty of Psychology, Department of Experimental Psychology, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. m.werrij@psychology.unimaas.nl
Objective:
Comorbid depression has been found to increase morbidity in a variety of disorders. This study aimed to investigate whether the presence of depressive symptoms in overweight and obese people is related to increased specific eating psychopathology and decreased self-esteem.
Methods:
Overweight/obese people seeking dietary treatment were grouped according to their scores on the Beck Depression Inventory (BDI), resulting in a mildly to moderately depressed group (BDI > or = 10; n = 66; the symptomatic group) and a non-depressed group (BDI < 10; n = 83). Eating psychopathology was measured by the Eating Disorder Examination-Questionnaire (EDE-Q); self-esteem was measured by the Rosenberg Self-Esteem Scale.
Results:
Symptomatic people had more shape, weight and eating concerns (P-values < 0.001); scored higher on restraint (P < 0.01); had lower self-esteem (P < 0.001); and had a higher BMI (P < 0.05) than non-depressed people. Furthermore, the percentage of bingers was higher in the symptomatic group (P < 0.01).
Conclusion:
Symptomatic participants suffered more than non-depressed participants, and not only from their depression.
Practice Implications:
For dieticians treating overweight and obese people, the BDI is a useful instrument for identifying the subgroup with depressive symptoms--the group that is at risk for (eating) psychopathology.
Related Concept Videos
Obesity
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Stress Prevention and Stress Management Techniques IV
Antidepressant Drugs: MAOIs and Other Agents

